Research on Anti-lipogenic Effect of Sobuncheong-eum on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease
![]() |
Lee, Hye-in
(College of Oriental Medicine, Dongsin University)
Kim, Ji-su (College of Oriental Medicine, Dongsin University) Kim, Cheon-jung (College of Oriental Medicine, Dongsin University) Kim, Ha-na (College of Oriental Medicine, Dongsin University) Yang, Tae-jun (College of Oriental Medicine, Dongsin University) Jeong, Sang-jun (College of Oriental Medicine, Dongsin University) Choi, Chang-Won (College of Oriental Medicine, Dongsin University) |
1 | Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23. DOI |
2 | Angulo P. Nonalcoholic fatty liver disease. Revista de gastroenterologia de Mexico. 2005;70 Suppl 3:52-6. |
3 | Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413-9. DOI |
4 | Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clinics in liver disease. 2009;13(4):511-31. DOI |
5 | Popov VB, Lim JK. Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss. Journal of clinical and translational hepatology. 2015;3(3):230-8. DOI |
6 | Yeon JE. Nonalcoholic Fatty Disease : pathogenesis and treatment. J of KAHP. 2006;4:132-9. |
7 | Lee NG. Hyeontojuseog Gyeongagjeonseo. Seoul: Bubin Publishers Co, 2007:1021. |
8 | Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, et al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. The Journal of physiology. 2006;574(Pt 1):41-53. DOI |
9 | Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes & development. 2000;14(22):2819-30. DOI |
10 | Pettinelli P, Obregon AM, Videla LA. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. Nutricion hospitalaria. 2011;26(3):441-50. |
11 | Shi KQ, Fan YC, Liu WY, Li LF, Chen YP, Zheng MH. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis. Molecular biology reports. 2012;39(10):9715-22. DOI |
12 | Traditional Chinese Association. Guidelines for Diagnosis and Treatment of Common Internal Diseases in Chinese Medicine Diseases of Modern Medicine. Beijing: China Traditional China Medicine Publisher, 2008:153. |
13 | Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiological reviews. 2009;89(3):1025-78. DOI |
14 | Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Harima M, Suzuki K, et al. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. The Journal of nutritional biochemistry. 2013;24(5):796-802. DOI |
15 | Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta physiologica. 2009;196(1):81-98. DOI |
16 | Pasarin M, Abraldes JG, Rodriguez-Vilarrupla A, La Mura V, Garcia-Pagan JC, Bosch J. Insulin resistance and liver microcirculation in a rat model of early NAFLD. Journal of hepatology. 2011;55(5):1095-102. DOI |
![]() |